![4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid](https://static.cymitquimica.com/products/3D/img/NAA18287.png "Click to enlarge")
4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid
CAS: 13182-87-1
Ref. 3D-NAA18287
| 5g | To inquire | ||
| 10g | To inquire |
Product Information
- 4-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid
- Butanedioic acid, 1-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl] ester
- Butanedioic acid, mono(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl) ester
- Imidazole-1-ethanol, 2-methyl-5-nitro-, hydrogen succinate (ester)
- Metronidazole hemisuccinate
- Metronidazole hydrogen succinate
- Metronidazole monosuccinate
- Succinic acid, 2-(2-methyl-5-nitroimidazol-1-yl)ethyl ester
- Succinic acid, mono[2-(2-methyl-5-nitroimidazol-1-yl)ethyl] ester
4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid is a nitroimidazole that has been shown to be effective in the treatment of cancer. It inhibits cancer by interfering with the synthesis of DNA, leading to cell death. 4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid can also inhibit bacterial growth and kill bacteria through the production of reactive oxygen species. This drug has been shown to produce genotoxic impurities in laboratory animals, which may lead to mutations and cancer. The structure of 4-[2-(2methyl 5 nitro 1 H imidazol 1 yl)ethoxy]4 oxobutanoic acid is characterized by a pyrazole ring with two methyl substituents on the nitrogen
Chemical properties
Technical inquiry about: 3D-NAA18287 4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
